NIBR189

GPR183 agonist

Also Known As:

(E)-3-(4-bromophenyl)-1-(4-(4-methoxybenzoyl)piperazin-1-yl)prop-2-en-1-one

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Weight Loss (Weight Reduction) 12/01/2023 - "Conversely, mice treated with the EBI2/GPR183 inhibitor NIBR189 displayed a modest increase in lung viral load only at late time points but no change in weight loss. " 09/13/2022 - "Conversely, mice treated with the EBI2/GPR183 inhibitor NIBR189 displayed a modest increase in lung viral load only at late time points, but no change in weight loss. "